Yorkshire Knee Clinic surgeons have been hosting four young consultants on a European Knee Society Travelling Fellowship. YKC’s Nick London explains the value of travel for consultants eager to learn their craft.
A landmark study of partial knee replacement implants commissioned by YKC’s Nick London has exploded the last remaining myth of mobile-bearing partial knees and confirmed that “there is now no one single advantage of mobile bearings over fixed”.
A partial knee implant with a fixed bearing or a mobile one: which is better?
If removing parts of a torn meniscus is ineffective, as a new study indicates, is there ever a good reason to carry out a meniscectomy? YKC’s Jim Newman explains.
A DNA test promises to transform knee replacement surgery for patients with metal allergies. YKC’s Jim Newman identifies a few issues with the science.
Pontefract Hospital, part of Mid Yorks NHS Teaching Trust for which YKC’s Jim Newman is Clinical Service Unit Director, has just been awarded official Elective Orthopaedic Hub status by GIRFT (Getting it Right First Time). Here, Jim explains why that accolade matters to NHS and private patients.
A partial knee implant with a fixed bearing or a mobile one: which is better? There’s one clear winner.
Are we really any nearer to being able to regrow cartilage in the knee? YKC’s Nick London is excited by the science and frustrated by the often sensationalist reporting of it.
Arthritis UK has called on the NHS to scrap BMI threshold policies used to ration surgeries. YKC’s Nick London agrees.
Exercise has long been seen as the most effective non-surgical way of alleviating osteoarthritis symptoms. Yet a new study suggests that may not be the case. So if you’re suffering from osteoarthritis, what are you supposed to do with this information? YKC’s Nick London shares his opinion.
What is radiofrequency nerve ablation? And does it have a role to play in alleviating the pain of osteoarthritis? YKC’s Dave Duffy looks at this FDA-approved treatment.
Better-prepared patients. Improved recovery. Better overall health outcomes. YKC’s Dave Duffy looks at the potential impact of semaglutide (e.g. Ozempic) on knee replacement surgery for patients with type 2 diabetes.